Evidence map›Paper›PMID 20368557›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival.

Yanhong Liu, Sanjay Shete, Carol J Etzel, Michael Scheurer, George Alexiou, Georgina Armstrong, Spyros Tsavachidis, Fu-Wen Liang, Mark Gilbert, Ken Aldape and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 3 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 3 syntheses or guidelines pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Regulator of telomere elongation helicase 1 (RTEL1) rs6010620 polymorphism contribute to increased risk of glioma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Annals of nuclear medicine · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Pharmacogenomics and personalized medicine · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Yanhong LiuDepartments of Epidemiology,Neuro-Oncology, and Pathology, TheUniversity of Texas MD Anderson CancerCente, Houston, TX 77030, USA. mbondy@mdanderson.org
Sanjay Shete
Carol J Etzel
Michael Scheurer
George Alexiou
Georgina Armstrong
Spyros Tsavachidis
Fu-Wen Liang
Mark Gilbert
Ken Aldape
Terri Armstrong
Richard Houlston
Fay Hosking
Lindsay Robertson
Yuanyuan Xiao
John Wiencke
Margaret Wrensch
Ulrika Andersson
Beatrice S Melin
Melissa Bondy
The University of Texas System · US

Funding

Tissue CoreP50CA097257 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joseph F Costello · 2002 to 2026
$57.4M
GENETIC EPIDEMIOLOGY OF MALIGNANT GLIOMAR01CA052689 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WIENCKE, JOHN K., WRENSCH, MARGARET R. · 1991 to 2015
$20.5M
Genetic Epidemiology of Glioma International ConsortiumR01CA119215 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BONDY, MELISSA L. · 2006 to 2010
$11.9M
MOLECULAR EPIDEMIOLOGY OF GLIOMASR01CA070917 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI BONDY, MELISSA L · 1996 to 2004
$3.0M
Risk models:environment versus metabolic polymorphismsK07CA093592 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ETZEL, CAROL J · 2003 to 2007
$679k
NCI NIH HHS 5R01CA070917NCI NIH HHS 5R01CA119215NCI NIH HHS K07 CA093592NCI NIH HHS K07CA093592NCI NIH HHS P50 CA097257NCI NIH HHS P50CA097257NCI NIH HHS R01 CA052689NCI NIH HHS R01 CA070917NCI NIH HHS R01 CA119215NCI NIH HHS R01CA52689Wellcome Trust
6 · The paper itself

Abstract

purposeGlioblastoma (GBM) is the most common and aggressive type of glioma and has the poorest survival. However, a small percentage of patients with GBM survive well beyond the established median. Therefore, identifying the genetic variants that influence this small number of unusually long-term survivors may provide important insight into tumor biology and treatment. PATIENTS AND

methodsAmong 590 patients with primary GBM, we evaluated associations of survival with the 100 top-ranking glioma susceptibility single nucleotide polymorphisms from our previous genome-wide association study using Cox regression models. We also compared differences in genetic variation between short-term survivors (STS; <or= 12 months) and long-term survivors (LTS; >or= 36 months), and explored classification and regression tree analysis for survival data. We tested results using two independent series totaling 543 GBMs.

resultsWe identified LIG4 rs7325927 and BTBD2 rs11670188 as predictors of STS in GBM and CCDC26 rs10464870 and rs891835, HMGA2 rs1563834, and RTEL1 rs2297440 as predictors of LTS. Further survival tree analysis revealed that patients >or= 50 years old with LIG4 rs7325927 (V) had the worst survival (median survival time, 1.2 years) and exhibited the highest risk of death (hazard ratio, 17.53; 95% CI, 4.27 to 71.97) compared with younger patients with combined RTEL1 rs2297440 (V) and HMGA2 rs1563834 (V) genotypes (median survival time, 7.8 years).

conclusionPolymorphisms in the LIG4, BTBD2, HMGA2, and RTEL1 genes, which are involved in the double-strand break repair pathway, are associated with GBM survival.

Indexed as

DNA Breaks, Double-StrandedDNA RepairSurvivorsAge FactorsBrain NeoplasmsCarrier ProteinsChi-Square DistributionDecision TreesDNA HelicasesDNA Ligase ATPDNA LigasesFemaleGene Expression Regulation, NeoplasticGenetic Predisposition to DiseaseGlioblastomaHMGA2 ProteinBTBD2 protein, humanCarrier ProteinsDNA HelicasesDNA Ligase ATPDNA LigasesHMGA2 ProteinLIG4 protein, humanRTEL1 protein, human

Identifiers

PMID20368557
PMCPMC2881725
OpenAlexW2154853471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.